The vulvodynia treatment industry is currently worth US$ 5.6 billion, and it is anticipated to reach US$ 8 billion by 2028, growing at an impressive CAGR of 6.3% from 2022 to 2028. In order to cater to the need of the growing number of patients, companies are looking out for treatments and drugs that can subside …